Greencore Group (GNC)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 278.60 |
|---|---|
| 52-week range | 191.10 – 307.50 |
| Return, 1 month / 3 months | +14.2% / +15.8% |
| Return, 1 year / 3 years | +17.8% / +217.1% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 31.5% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 546.48M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Greencore Group is a convenience food manufacturer based in Dublin, Ireland, with much of its production in the United Kingdom. It makes chilled prepared foods such as sandwiches, salads, ready meals, soups and sushi, supplying supermarkets, convenience stores and food service customers. The company focuses on freshly prepared, own-brand products made in its network of food production sites, working closely with retail partners to develop and supply everyday chilled foods for shoppers.
Greencore Group trades under the code GNC on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Greencore Group (GNC) trades on the London Exchange in UK. It last closed at GBX 278.60 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,260 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.8% and over the last three months it rose 15.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.1% | ||
| From 52-week high | -9.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.8% | ||
| 6-month return | 9.4% | ||
| 12-month return, skipping the last month | 3.2% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 546.48M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 3 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | +14.2% |
| 3 months | +15.8% |
| 6 months | +9.4% |
| 1 year | +17.8% |
| 3 years | +217.1% |
| 5 years | +120.1% |
Signals
| 50-day / 200-day average | 257.08 / 246.30 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jan 2026 | GBP 0.0260 |
| 9 Jan 2025 | GBP 0.0200 |
| 2 Jan 2020 | GBP 0.0375 |
| 30 May 2019 | GBP 0.0245 |
| 10 Jan 2019 | GBP 0.0337 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.